Rabeprazole sodium and Hydromorphone hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole sodium and Hydromorphone hydrochloride. Common interactions include blood pressure systolic increased among females and pneumonia bacterial among males.

The phase IV clinical study analyzes what interactions people who take Rabeprazole sodium and Hydromorphone hydrochloride have. It is created by eHealthMe based on reports of 41 people who take Rabeprazole sodium and Hydromorphone hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jun, 10, 2023

41 people who take Rabeprazole sodium and Hydromorphone hydrochloride together, and have interactions are studied.

What is Rabeprazole sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 13,044 Rabeprazole sodium users for its effectiveness, alternative drugs and more.

What is Hydromorphone hydrochloride?

Hydromorphone hydrochloride has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 9,742 Hydromorphone hydrochloride users for its effectiveness, alternative drugs and more.

Number of Rabeprazole sodium and Hydromorphone hydrochloride reports submitted per year:

Common Rabeprazole Sodium and Hydromorphone Hydrochloride drug interactions by gender *:

female:

Blood pressure systolic increased
Blood pressure increased
Pneumonia
Rheumatoid arthritis
Basal cell carcinoma
Cholelithiasis
Cystitis
Drug ineffective
Gallbladder obstruction
Cholecystitis

male:

Pneumonia bacterial
Pneumonitis
Hypertension
Hypothyroidism
Mucosal inflammation
Myocardial infarction
Neurotoxicity
Sleep apnoea syndrome
Tachycardia
Blood cholesterol increased

Common Rabeprazole Sodium and Hydromorphone Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood pressure systolic increased
Basal cell carcinoma
Blood pressure increased
Cystitis
Drug ineffective
Pneumonia
Blood cholesterol increased
Hypersensitivity
Hypertension
Hypothyroidism

50-59:

Pneumonia bacterial
Pneumonitis

60+:

Rheumatoid arthritis
Fear of disease
Asthenia
Blindness
Cardiac disorder
Clostridial infection
Confusional state
Constipation
Death
Dehydration

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 22 people, 53.66%
Depression: 4 people, 9.76%
Hypersensitivity: 3 people, 7.32%
High Blood Pressure: 3 people, 7.32%
Anaesthesia: 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole sodium and Hydromorphone hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Rabeprazole sodium (13,044 reports)
Hydromorphone hydrochloride (9,742 reports)